Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
7.95
+0.13 (1.66%)
Oct 20, 2025, 2:41 PM EDT
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $30.73 billion as of October 20, 2025. Its market cap has decreased by -4.28% in one year.
Market Cap
30.73B
Enterprise Value
69.29B
Revenue
54.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.95
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 30.73B, an increase of 424.33%. That is a compound annual growth rate of 5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 30.73B | 56.07% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | 58.13B | -27.55% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |